Actively Recruiting
Radicle Clarity™ RBB: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes
Led by Radicle Science · Updated on 2025-12-22
850
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
R
Radicle Science
Lead Sponsor
J
Jeff Bland
Collaborating Sponsor
AI-Summary
What this Trial Is About
A Randomized, Double-Blind, Placebo-Controlled Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes
CONDITIONS
Official Title
Radicle Clarity™ RBB: A Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults, at least 21 years of age at the time of electronic consent, inclusive of all ethnicities, races, and gender identities
- Assigned sex at birth will determine sex-specific recruitment and surveys (male vs female) employed, when needed
- Resides in the United States
- Has the opportunity for at least 30% improvement in their primary health outcome
- Expresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the study
You will not qualify if you...
- Report being pregnant, trying to become pregnant, or breastfeeding
- Unable to provide a valid US shipping address and mobile phone number
- Reports current enrollment in another clinical trial
- Reports being a heavy drinker (defined as drinking 3 or more alcoholic beverages per day)
- Unable to read and understand English
- Reports a current and/or recent (up to 3 months ago) major illness and/or surgery that poses a known, significant safety risk
- Reports a diagnosis of cardiac dysfunction, liver or kidney disease that presents a known contraindication and/or significant safety risk with any of the study product ingredients, including NYHA Class III or IV congestive heart failure, atrial fibrillation, uncontrolled arrhythmias, cirrhosis, end-stage liver disease, stage 3b or 4 chronic kidney disease, or kidney failure
- Reports taking medications with a well-established moderate or severe interaction posing a substantial safety risk with any study product ingredients, including anticoagulants, antihypertensives, anxiolytics, antidepressants, chemotherapy, immunotherapy, sedative hypnotics, seizure medications, medications warning against grapefruit consumption, corticosteroids over 5 mg per day, diabetic medications, oral anti-infectives for acute infections, antipsychotics, MAOIs, or thyroid products
- Reports current use of the primary ingredient(s) and/or similar products to the active study products that may limit study product effects
- Lack of reliable daily access to the internet
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Radicle Science Inc.
Del Mar, California, United States, 92014
Actively Recruiting
Research Team
S
Study Manager
CONTACT
S
Susan Hewlings
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here